
Loading, please wait...

Loading, please wait...







A breakthrough study identifies Tertiary Lymphoid Structures and CXCL13 T-follicular helper cells as central drivers of intracranial aneurysm progression and rupture risk, suggesting new pharmacological targets to prevent subarachnoid hemorrhage.



